Ann: Admedus to host Investor Webinar, page-76

In the interest of transparency I am not one of the doctors. And Russ are you on the board or staff of Admedus?
I don't think a little controversy hurts the dialogue.
I understand your point clearly as well Stonemason. I was looking at from the point that by splitting the company we would not lose anything in fact gain in capacity to raise money.
I do not know the history of Cochlear or Gardisil but these 2 companies seem to have thrived by concentrating on one product.
If we split off the potential is to have 2 different companies equal or better than the above mentioned.
However I can also see the benefit of both products piggy backing each other as we go along.
I would not like to see though one dragging both under.
Just my thoughts